$2.88
-0.08-2.70%
At Close: -
$3.00
0.124.01%
After Hours: Jul 3, 3:50 PM EDT
15 minutes delayed
Sutro Biopharma
STRONASDAQ
Sutro Biopharma (STRO) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestSutro Biopharma (NASDAQ:STRO) Stock Quotes, Forecast and News Summary
Sutro Biopharma Stock (NASDAQ: STRO) stock price, news, charts, stock research, profile.
| Open | $2.95 |
| Close | $2.88 |
| Volume / Avg. | 414.87K / 883.70K |
| Day Range | 2.87 - 3.07 |
| 52 Wk Range | 2.01 - 6.13 |
| Market Cap | $245.01M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 36 |
| Short Interest | 2.82% |
| Days to Cover | 4.51 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Sutro Biopharma Inc
Sector
Health Care
Industry
Biotechnology
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It i...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Sutro Biopharma (STRO) stock?
You can purchase shares of Sutro Biopharma (NASDAQ:STRO) through any online brokerage.
Who are Sutro Biopharma (STRO) competitors?
Other companies in Sutro Biopharma’s space includes: Macrogenics (NASDAQ:MGNX), Molecular Partners (NASDAQ:MOLN), Zura Bio (NASDAQ:ZURA), Renovaro (NASDAQ:RENB) and Tectonic Therapeutic (NASDAQ:TECX).
What is the target price for Sutro Biopharma (STRO) stock?
There is no analysis for Sutro Biopharma.
What is the forecast for Sutro Biopharma (STRO) stock?
Sutro Biopharma has a consensus price target of $14.44.
Current stock price for Sutro Biopharma (STRO)?
The stock price for Sutro Biopharma (NASDAQ: STRO) is $2.9954 last updated July 3, 2024 at 3:50 PM EDT.
Does Sutro Biopharma (STRO) pay a dividend?
There are no upcoming dividends for Sutro Biopharma.
When is Sutro Biopharma (NASDAQ:STRO) reporting earnings?
Sutro Biopharma’s Q2 earnings are confirmed for Thursday, August 8, 2024.
Is Sutro Biopharma (STRO) going to split?
There is no upcoming split for Sutro Biopharma.
What sector and industry does Sutro Biopharma (STRO) operate in?
Sutro Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.